The MTO1 gene helps mitochondria, the parts of cells that make energy, build the proteins they need to work well. When the MTO1 gene does not work properly, cells may struggle to make enough energy, which can lead to developmental delay, muscle weakness, seizures, or heart problems such as cardiomyopathy. This gene plays an important role in tissues that use a lot of energy, especially the brain, muscles, and heart. Pathogenic variants in the MTO1 gene cause a rare inherited mitochondrial condition.
What is a gene?
Genes are stretches of DNA that hold instructions cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly determine when certain processes happen, where they happen, and how active they are. As a group, genes affect how the body grows and works, and they can influence your response to food, stress, and medications. For a deeper look at this topic, visit the LearnHub.
Overview
MTO1Gene function
What if the gene works
The MTO1 gene helps mitochondria, your cells’ energy centers, make proteins correctly. This supports efficient energy production, especially in tissues with high energy needs such as the brain, muscles, and heart.
Risk
What if the gene does not work
More disruptive variants in the MTO1 gene can cause a mitochondrial condition that often affects organs needing a lot of energy, leading to developmental delay, muscle weakness, lactic acidosis, and heart disease. Milder variants may cause later onset or fewer features.
Treatment
What does that mean for your treatment
No MTO1-specific treatment or drug selection approach is currently established in clinical guidelines. Care is guided by the person’s symptoms and overall mitochondrial disease management, rather than by an MTO1-directed medicine.
Conditions associated with MTO1
Gene function
What if the gene works
Many of your cells depend on the MTO1 gene to keep mitochondria running smoothly. Mitochondria are the parts of cells that turn food and oxygen into usable energy. Inside them, the MTO1 gene helps fine tune protein making so key proteins for energy production are made accurately.
Inside mitochondria, the MTO1 gene adds a small chemical mark to certain transfer RNAs, the helper molecules that read genetic instructions. This tuning helps mitochondria match the right building blocks to the right code during protein making.
The marked transfer RNAs help mitochondria make a small set of proteins from their own genetic instructions. These proteins are core parts of the system that captures energy from food.
By supporting accurate protein production in mitochondria, the MTO1 gene helps cells maintain a steady energy supply. This is one of the main ways the MTO1 gene helps mitochondria make energy for everyday body functions.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MTO1 gene can make the mitochondrial protein less stable or less able to help mitochondria read key instructions accurately. In practical terms, how MTO1 gene variants affect mitochondrial energy production depends on how much this step is disrupted, which can reduce the cell’s ability to make energy. Some variants have a milder effect, while more severe variants can cause a larger loss of function and are often linked to earlier or more marked features of MTO1-related disease.
How variants are linked to conditions
Pathogenic variants in the MTO1 gene cause a mitochondrial condition often called combined oxidative phosphorylation deficiency 10. People with this diagnosis may have hypertrophic cardiomyopathy, lactic acidosis, developmental delay, muscle weakness, seizures, or feeding and breathing problems, and severity can vary widely. In everyday terms, MTO1 gene variants linked to mitochondrial disease can affect the heart, brain, and muscles from infancy or childhood.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MTO1, risk is mainly tied to inheritance: a child is affected when they inherit a disease-causing MTO1 change from both parents. There is not yet broadly confirmed evidence that lifestyle or environmental factors meaningfully increase or reduce the genetic risk linked to MTO1.
Inheritance of MTO1 variants
MTO1-related conditions are inherited in an autosomal recessive pattern, which means a person usually inherits one MTO1 variant from each parent. In families asking about MTO1 gene inheritance, parents are often healthy carriers because having one changed copy usually does not cause the condition. When both parents carry an MTO1 variant, each pregnancy has a 25% chance of being affected, a 50% chance of resulting in a carrier child, and a 25% chance of resulting in a child with two typical copies of the gene. Because the MTO1 gene is on an autosome, this pattern is the same for boys and girls.
What does my MTO1 result mean for my family?
For families with an MTO1-related condition, the pattern is usually recessive. This often means parents are healthy carriers, and brothers or sisters may also be affected or be carriers. Other relatives, especially siblings and relatives planning children, may also want to learn whether the variant runs in the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for MTO1 variants is usually done on a blood sample, and sometimes saliva, using a gene panel, exome sequencing, or genome sequencing. The lab reads the MTO1 gene to look for changes and may compare them with known disease-linked variants. Results can help confirm whether symptoms fit an MTO1-related condition.
When should I consider getting a genetic test?
Consider testing for changes in the MTO1 gene if a child has unexplained early heart muscle disease, developmental delay, low muscle tone, seizures, or repeated high lactic acid levels. It can also be useful when a close family member has an MTO1-related condition or both parents are known carriers.
A genetic result is only one part of your health story
A genetic result can be informative, yet how much it reveals depends on the condition and on the type of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered together with other aspects of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, so the same treatment may work better for one person and less well for another. These differences are common and can also influence the chance of side effects or how sensitive someone is to a medication. Genetics is one part of the picture, along with age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences can shape a person’s response to medications. It studies connections between genes and drugs to help explain why the same treatment may work differently in different people. With many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can support more informed and individualized treatment decisions. If you want to read more about this subject, you can learn more in the LearnHub.
Drugs influenced by the MTO1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or what side effects they may cause. If you have concerns about medicines, side effects, or health changes, it is best to talk with your doctor or pharmacist.